Holocene Advisors, LP Acadia Pharmaceuticals Inc Transaction History

Holocene Advisors, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $658,397 - $1.38 Million	50,607 New	50,607 $713,000
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $151,408 - $224,449	-10,047 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $22,941 - $33,008	-1,021 Reduced 9.22%	10,047 $226,000
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $297,065 - $433,201	11,068	11,068 $333,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.